[1]
“Combination of intravenous immunoglobulin, oral prednisone, and methotrexate for managing scleromyxedema: case report and literature discussion”, Dermatol Reports, vol. 16, no. 2, Aug. 2023, doi: 10.4081/dr.2023.9803.